Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone Pfizer Inc.

PFE

Tesla Will Further Dominate EV Market In 2023, Says Analyst — Why He Is Slashing Price Target By 24%

By Shanthi Rexaline

December 29, 6:29 AM

Tesla Inc.’s (NASDAQ: TSLA) stock price received another price target cut, underlining tempered expectations concerning the stoc

TSLA

Take-Two’s CEO On Microsoft/Activision Deal: ‘What’s Good For Them Is Also Good For The Industry’

By Franca Quarneti

May 18, 12:07 PM

Strauss Zelnick, CEO of Take-Two Interactive Software Inc. (NASDAQ: TTWO) is sharing his views on the potential impact of Microsoft Corporation's (NASDAQ: MSFT) proposed

ATVI

Oppenheimer Downgrades BioCryst Pharmaceuticals to Perform

Related Posts

Loop Capital Initiates Coverage On Walgreens Boots Alliance with Buy Rating, Announces Price Target of $45

Phase 3 Studies Of Pfizer’s Novel Antibiotic Combination Offer New Treatment Hope For Patients With Multidrug-Resistant Infections And Limited Treatment Options

Tesla Will Further Dominate EV Market In 2023, Says Analyst — Why He Is Slashing Price Target By 24%

Take-Two’s CEO On Microsoft/Activision Deal: ‘What’s Good For Them Is Also Good For The Industry’